4.6 Review

Interplay between Cellular Metabolism and the DNA Damage Response in Cancer

期刊

CANCERS
卷 12, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/cancers12082051

关键词

DNA repair; DNA damage; DNA damage response; metabolism; high-throughput technologies

类别

资金

  1. Austrian Science Fund [P 33024]
  2. Austrian Academy of Sciences

向作者/读者索取更多资源

Metabolism is a fundamental cellular process that can become harmful for cells by leading to DNA damage, for instance by an increase in oxidative stress or through the generation of toxic byproducts. To deal with such insults, cells have evolved sophisticated DNA damage response (DDR) pathways that allow for the maintenance of genome integrity. Recent years have seen remarkable progress in our understanding of the diverse DDR mechanisms, and, through such work, it has emerged that cellular metabolic regulation not only generates DNA damage but also impacts on DNA repair. Cancer cells show an alteration of the DDR coupled with modifications in cellular metabolism, further emphasizing links between these two fundamental processes. Taken together, these compelling findings indicate that metabolic enzymes and metabolites represent a key group of factors within the DDR. Here, we will compile the current knowledge on the dynamic interplay between metabolic factors and the DDR, with a specific focus on cancer. We will also discuss how recently developed high-throughput technologies allow for the identification of novel crosstalk between the DDR and metabolism, which is of crucial importance to better design efficient cancer treatments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Mapping the Human Kinome in Response to DNA Damage

Michel Owusu, Peter Bannauer, Joana Ferreira da Silva, Thanos P. Mourikis, Alistair Jones, Peter Majek, Michael Caldera, Marc Wiedner, Charles-Hugues Lardeau, Andre C. Mueller, Joerg Menche, Stefan Kubicek, Francesca D. Ciccarelli, Joanna I. Loizou

CELL REPORTS (2019)

Article Multidisciplinary Sciences

Klebsiella oxytoca enterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubule-stabilizing activities

Katrin Unterhauser, Lisa Poeltl, Georg Schneditz, Sabine Kienesberger, Ronald A. Glabonjat, Maksym Kitsera, Jakob Pletz, Fernando Josa-Prado, Elisabeth Dornisch, Christian Lembacher-Fadum, Sandro Roier, Gregor Gorkiewicz, Daniel Lucena, Isabel Barasoain, Wolfgang Kroutil, Marc Wiedner, Joanna I. Loizou, Rolf Breinbauer, Jose Fernando Diaz, Stefan Schild, Christoph Hoegenauer, Ellen L. Zechner

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Hematology

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

Barbara Maurer, Harini Nivarthi, Bettina Wingelhofer, Ha Thi Thanh Pham, Michaela Schlederer, Tobias Suske, Reinhard Grausenburger, Ana-Iris Schiefer, Michaela Prchal-Murphy, Doris Chen, Susanne Winkler, Olaf Merkel, Christoph Kornauth, Maximilian Hofbauer, Birgit Hochgatterer, Gregor Hoermann, Andrea Hoelbl-Kovacic, Jana Prochazkova, Cosimo Lobello, Abbarna A. Cumaraswamy, Johanna Latzka, Melitta Kitzwoegerer, Andreas Chott, Andrea Janikova, Sarka Pospisilova, Joanna Loizou, Stefan Kubicek, Peter Valent, Thomas Kolbe, Florian Grebien, Lukas Kenner, Patrick T. Gunning, Robert Kralovics, Marco Herling, Mathias Mueller, Thomas Ruelicke, Veronika Sexl, Richard Moriggl

HAEMATOLOGICA (2020)

Article Medicine, Research & Experimental

Polymerase δ deficiency causes syndromic immunodeficiency with replicative stress

Cecilia Dominguez Conde, Oezlem Yuece Petronczki, Safa Baris, Katharina L. Willmann, Enrico Girardi, Elisabeth Salzer, Stefan Weitzer, Rico Chandra Ardy, Ana Krolo, Hanna Ijspeert, Ayca Kiykim, Elif Karakoc-Aydiner, Elisabeth Forster-Waldl, Leo Kager, Winfried F. Pickl, Giulio Superti-Furga, Javier Martinez, Joanna Loizou, Ahmet Ozen, Mirjam van der Burg, Kaan Boztug

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Multidisciplinary Sciences

Genome-scale CRISPR screens are efficient in non-homologous end-joining deficient cells

Joana Ferreira da Silva, Sejla Salic, Marc Wiedner, Paul Datlinger, Patrick Essletzbichler, Alexander Hanzl, Giulio Superti-Furga, Christoph Bock, Georg Winter, Joanna I. Loizou

SCIENTIFIC REPORTS (2019)

Article Oncology

Mutational Signatures Driven by Epigenetic Determinants Enable the Stratification of Patients with Gastric Cancer for Therapeutic Intervention

Jaqueline Ramalho Buttura, Monize Nakamoto Provisor Santos, Renan Valieris, Rodrigo Duarte Drummond, Alexandre Defelicibus, Joao Paulo Lima, Vinicius Fernando Calsavara, Helano Carioca Freitas, Vladmir C. Cordeiro de Lima, Thais Fernanda Bartelli, Marc Wiedner, Rafael Rosales, Kenneth John Gollob, Joanna Loizou, Emmanuel Dias-Neto, Diana Noronha Nunes, Israel Tojal da Silva

Summary: This study identified three mutational signatures related to DNA mismatch repair deficiency (dMMR) in gastric cancer, one of which can accurately discriminate tumors with MLH1 gene silencing caused by promoter hypermethylation. Classification based on mutational signature exposure can help identify patients with better prognosis in gastric cancer.

CANCERS (2021)

Article Biochemistry & Molecular Biology

FANCD2-Associated Nuclease 1 Partially Compensates for the Lack of Exonuclease 1 in Mismatch Repair

Katja Kratz, Mariela Artola-Boran, Saho Kobayashi-Era, Gene Koh, Goncalo Oliveira, Shunsuke Kobayashi, Andreia Oliveira, Xueqing Zou, Julia Richter, Masataka Tsuda, Hiroyuki Sasanuma, Shunichi Takeda, Joanna Loizou, Alessandro A. Sartori, Serena Nik-Zainal, Josef Jiricny

Summary: A study revealed a new exonuclease, FAN1, which can efficiently substitute for EXO1 in the mismatch repair process, with its functional complementation modulated by its interaction with MLH1. Loss of FAN1 exacerbates the mutational profile of EXO1-deficient cells, suggesting redundant action of these two nucleases in the same antimutagenic pathway.

MOLECULAR AND CELLULAR BIOLOGY (2021)

Article Oncology

High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells

Ruochen Jia, Leon Kutzner, Anna Koren, Kathrin Runggatscher, Peter Majek, Andre C. Mueller, Michael Schuster, Christoph Bock, Joanna I. Loizou, Stefan Kubicek, Robert Kralovics

Summary: Mutations of calreticulin (CALR) are the second most common driver mutations in essential thrombocythemia and primary myelofibrosis. A study identified synthetic lethality with compounds targeting the ATR-CHK1 pathway in CALR mutated cells, highlighting the potential therapeutic target in CALR mutated hematopoietic cells. CHK1 inhibitors induced replication stress and S-phase cell cycle arrest in CALR mutated cells, demonstrating specificity for the oncogenic activation by the mutant CALR.

BLOOD CANCER JOURNAL (2021)

Article Multidisciplinary Sciences

Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair

J. Ferreira da Silva, G. P. Oliveira, E. A. Arasa-Verge, C. Kagiou, A. Moretton, G. Timelthaler, J. Jiricny, J. Loizou

Summary: Prime editing is a powerful genome engineering approach that can introduce various modifications into the genome. This study identifies the mismatch repair pathway as inhibitory for Prime editing, and loss of mismatch repair enhances its efficiency.

NATURE COMMUNICATIONS (2022)

Article Oncology

Clickable Cisplatin Derivatives as Versatile Tools to Probe the DNA Damage Response to Chemotherapy

Amandine Moretton, Jana Slyskova, Marwan E. Simaan, Emili A. Arasa-Verge, Mathilde Meyenberg, D. Alonso Cerron-Infantes, Miriam M. Unterlass, Joanna I. Loizou

Summary: In this study, a series of cisplatin derivatives compatible with click chemistry were synthesized to investigate the repair of DNA crosslinks and cellular responses. It was found that these compounds bind to DNA and generate DNA damage. They can be visualized and quantified in cells through fluorescence probes and biotin tagging, respectively. Furthermore, one of the compounds can be used to identify DNA repair proteins.

FRONTIERS IN ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability

Amandine Moretton, Savvas Kourtis, Antoni Ganez Zapater, Chiara Calabro, Maria Lorena Espinar Calvo, Frederic Fontaine, Evangelia Darai, Etna Abad Cortel, Samuel Block, Laura Pascual-Reguant, Natalia Pardo-Lorente, Ritobrata Ghose, Matthew G. Vander Heiden, Ana Janic, Andre C. Mueller, Joanna Loizou, Sara Sdelci

Summary: This study investigates the role of cellular metabolism in DNA damage repair and identifies Peroxiredoxin 1 (PRDX1) as a contributor to this process. By integrating functional genomics with chromatin proteomics and metabolomics, the interplay between cellular metabolism and the DNA damage response is elucidated.

MOLECULAR SYSTEMS BIOLOGY (2023)

Article Cell Biology

NUDT6 and NUDT9, two mitochondrial members of the NUDIX family, have distinct hydrolysis activities

Louis Debar, Layal Ishak, Amandine Moretton, Saber Anoosheh, Frederic Morel, Louise Jenninger, Isabelle Garreau-Balandier, Patrick Vernet, Anders Hofer, Siet Van den Wildenberg, Geraldine Farge

Summary: The NUDIX hydrolase superfamily consisting of 22 members can hydrolyze various phosphorylated molecules. In this study, NUDT6 and NUDT9 were found to play roles in mitochondria, and their deficiency led to increased respiratory chain activity and altered expression of mitochondrial respiratory chain complexes. Furthermore, NUDT6 showed higher activity towards NADH, while NUDT9 displayed higher activity towards ADPR.

MITOCHONDRION (2023)

Review Oncology

Targeting the DNA Repair Enzyme Polymerase theta in Cancer Therapy

Anna Schrempf, Jana Slyskova, Joanna Loizou

Summary: Targeted cancer therapies focusing on POLQ, an error-prone translesion polymerase involved in DNA repair, represent a promising approach in personalized cancer treatment. Inhibition of POLQ, currently under development, shows potential for more effective cancer therapies in the future.

TRENDS IN CANCER (2021)

暂无数据